SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 189 filers reported holding SANGAMO THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.50 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,940,936 | -51.1% | 6,474,348 | 0.0% | 0.03% | -62.8% |
| Q2 2023 | $8,060,563 | -29.3% | 6,474,348 | 0.0% | 0.08% | -90.7% |
| Q1 2023 | $11,394,852 | +24.5% | 6,474,348 | +113.9% | 0.84% | +110.2% |
| Q4 2022 | $9,154,285 | -40.6% | 3,026,210 | 0.0% | 0.40% | -12.6% |
| Q3 2022 | $15,403,000 | +23.5% | 3,026,210 | 0.0% | 0.46% | +25.8% |
| Q2 2022 | $12,468,000 | +112.7% | 3,026,210 | +209.5% | 0.36% | +33.2% |
| Q1 2022 | $5,861,000 | +42.7% | 977,663 | +81.1% | 0.27% | +10.9% |
| Q4 2021 | $4,108,000 | -16.9% | 539,860 | 0.0% | 0.25% | +133.0% |
| Q3 2021 | $4,945,000 | – | 539,860 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Golden State Equity Partners | 154,360 | $897,000 | 0.45% |
| Rhenman & Partners Asset Management AB | 761,429 | $4,424,000 | 0.44% |
| Lombard Odier Asset Management (Switzerland) SA | 860,702 | $5,001,000 | 0.39% |
| WASATCH ADVISORS LP | 10,576,997 | $61,452,000 | 0.30% |
| Rokos Capital Management LLP | 977,663 | $5,861,000 | 0.27% |
| KLK CAPITAL MANAGEMENT LLC | 44,323 | $258,000 | 0.26% |
| Long Focus Capital Management, LLC | 340,000 | $1,975,000 | 0.25% |
| Vanguard Capital Wealth Advisors | 33,380 | $193,000 | 0.14% |
| Fort Sheridan Advisors LLC | 73,978 | $430,000 | 0.13% |
| Delphia (USA) Inc. | 20,983 | $122,000 | 0.09% |